Target intelligence / Profile preview

Norovirus GII.4 major capsid protein VP1 protruding domain (VP1 P domain) (VP1 P domain)

Target
VP1 P domain
Molecular classification
Viral capsid protein, Viral attachment protein, Other
01

Overview

The protruding (P) domain of the Norovirus GII.4 major capsid protein VP1 is a critical structural component of the viral capsid that mediates host cell attachment and entry (Prasad et al., 1999; UniProt A0A172QPU7). It is divided into two subdomains, P1 and P2, with the P2 subdomain being the most surface-exposed and hypervariable region of the virus (Tan et al., 2008). This domain contains the binding sites for histo-blood group antigens (HBGAs), which act as essential attachment factors or co-receptors for norovirus infection (Hutson et al., 2002). Because of its accessibility and role in receptor binding, the P domain is the primary target for neutralizing antibodies and the focus of vaccine development efforts, including virus-like particle (VLP) and P-particle candidates (Takeda/HilleVax TAK-214; Vaxart VXA-NVV-104). However, the GII.4 genotype is characterized by rapid antigenic drift within the P domain, allowing the virus to escape host herd immunity and cause periodic global pandemics of acute gastroenteritis (Lindesmith et al., 2008). Therapeutic strategies targeting this domain include VLP-based vaccines and experimental monoclonal antibodies designed to block HBGA interactions (Ford-Siltz et al., 2020).

Other names
P domainProtruding domainVP1 P-domainP1 subdomainP2 subdomainCapsid protein P domain
02

Mechanism of action

Inhibition of viral attachment to host histo-blood group antigens (HBGAs) and neutralization of the virus by blocking the P2 subdomain binding interface.

03

Biological functions

Viral attachmentHost cell entryImmune responseAntigenic variationOther
04

Disease associations

InfectionOther
05

Safety considerations

Antigenic driftStrain-specific immunityImmune escape
06

Interacting drugs

TAK-214 (HIL-214)

3 more in the full profile.

07

Biomarkers

Secretor status (FUT2 genotype)Serum HBGA-blocking antibody titersViral load

Beyond the preview

Go deeper on Norovirus GII.4 major capsid protein VP1 protruding domain (VP1 P domain) (VP1 P domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norovirus GII.4 major capsid protein VP1 protruding domain (VP1 P domain) (VP1 P domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call